GlassScriptPhysician profile
Erin C May
NPI 1124332002
$730.49
in general payments reported to CMS, 2019-2025
23 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $52.65 · 2021: $26.00 · 2022: $167 · 2023: $40.17 · 2024: $172 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $80.12 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $77.10 | 2023-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $76.28 | 2024-2025 | Paragard T 380a |
| Allergan, INC. | $64.99 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $48.45 | 2022 | |
| Therapeuticsmd, INC. | $45.05 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $38.44 | 2022-2025 | |
| Amag Pharmaceuticals, INC. | $35.81 | 2019-2020 | |
| Convatec INC. | $29.69 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.17 | 2021-2024 | |
| Exact Sciences Corporation | $22.74 | 2024 | Cologuard Collection Kit |
| Octapharma USA, INC. | $19.29 | 2025 | Fibryga |
| Hologic Sales and Service, LLC | $18.88 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Minerva Surgical, INC | $18.26 | 2024 | |
| Smith+Nephew, INC. | $16.55 | 2025 | Pico 7 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $14.90 | 2021 | |
| Aspira Women'S Health INC | $14.84 | 2024 | Ova1 |
| Roche Diagnostics Corporation | $14.78 | 2019 | |
| Biogen, INC. | $14.67 | 2024 | |
| Agile Therapeutics, INC. | $14.44 | 2022 | |
| Exeltis, USA INC. | $14.12 | 2020 | |
| Organon LLC | $13.26 | 2022 | |
| Merck Sharp & Dohme LLC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.